Management of in-transit melanoma and oligometastatic disease | 10 min
In-transit melanoma are intradermal and subcutaneous metastases located between the primary site and regional lymph node basin. In this brief recorded presentation, MIA’s Surgical Oncologist A/Prof Robyn Saw discusses:
- What is in-transit disease and what is the incidence?
- How is in-transit disease assessed?
- What treatment options are available?
- Oligometastatic disease and management principles
This presentation was recorded for the 2023 SET Registrars Teaching Day: Melanoma.
A/Prof Robyn Saw
General Surgeon, Melanoma Institute Australia | Associate Professor in Surgery, The University of Sydney | Head of Department, Melanoma and Surgical Oncology, Royal Prince Alfred Hospital
Declaration of Interest